TP53 and neoplasm: MIRA-1, for example, is a maleimide-type compound with low molecular weight that has been identified in screenings at the NCI data bank as a potential candidate for reactivating mutant p53-dependent cells in different human tumor cells, being more potent than PRIMA-1 in the induction of cell death [47].